North America Medical Collagen Market 2022-2028
MARKET OUTLOOK
According to Triton Market Research, North America’s medical collagen market is poised to develop with a CAGR of 6.12% over the estimated phase between 2022 and 2028. The United States and Canada together constitute the market in this region.
The United States has a sizable elderly population. In 2019, 16.5% of the people in the country were 65 years old or above. In old age, the ability of the cells to generate natural collagen decreases over time, which makes them vulnerable to numerous health problems.
These include problems related to the skin and bones, such as wrinkled skin and arthritis. Therefore, the elderly are increasingly opting for collagen supplements, which is expected to aid the medical collagen market’s growth in the coming years.
In Canada, a large number of people complain of various hair-related issues. Protein is required for optimal hair health. And when the body is protein-deficient, people experience various hair problems, such as dry scalp, hair fall, etc.
Collagen is a protein-rich source. Thus, consuming it helps combat these issues. Canadians are therefore increasingly inclining towards consuming collagen-based products, which is expected to drive the market’s growth.
However, despite the multiple benefits of these supplements, there are certain side-effects associated with their use. These include digestion issues and the risk of allergies. These side-effects of the supplements present a major challenge to the growth of the market in North America.
COMPETITIVE OUTLOOK
Integra Life Sciences, Connoils LLC, DSM, Tessenderlo Group, Lapi Gelatine, Symatese, Gelita, and Italgel are some of the noteworthy players in the medical collagen market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook